Health

Source link : https://newshealth.biz/health-news/targeted-lung-cancer-drug-aces-confirmatory-trial-in-frontline-setting/ CHICAGO — An oral targeted drug reduced the risk of disease progression or death by 35% compared with chemotherapy when given as first-line treatment for non-small cell lung cancer (NSCLC) patients with EGFR exon 20 insertions, a randomized trial showed. In patients with nonsquamous NSCLC, median progression-free survival (PFS) reached 10.3 months with sunvozertinib (Zegfrovy) […] […] More

Source link : https://newshealth.biz/health-news/bispecific-antibody-boosts-survival-in-relapsed-refractory-multiple-myeloma/ CHICAGO — Teclistamab (Tecvayli) monotherapy significantly improved survival compared with standard therapies in patients with multiple myeloma who had received up to three previous lines of therapy, the phase III MajesTEC-9 trial showed. The estimated 18-month progression-free survival (PFS) rate was 69.8% with teclistamab compared with 26.9% with pomalidomide (Pomalyst), bortezomib (Velcade), and dexamethasone (PVd) […] […] More

Source link : https://newshealth.biz/health-news/no-difference-in-complications-for-chiari-i-surgical-approaches-in-kids-study-shows/ For kids with Chiari type I malformation and syringomyelia, there was no significant difference in surgical complications whether they had decompression with or without duraplasty, a cluster-randomized controlled trial showed. The percentage of participants with complications within 6 months of surgery was 14% with posterior fossa decompression with duraplasty (PFD-D) and 6% with PFD alone. […] […] More

Source link : https://newshealth.biz/health-news/what-did-fda-vaccine-advisors-decide-this-week/ The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted daily, but keeping up can be a challenge. As an aid for our readers, and for a little amusement, here is a 10-question quiz based on the news of the […] […] More

Source link : https://newshealth.biz/health-news/guselkumab-adds-psa-structural-damage-inhibition-to-label/ Guselkumab is the only IL-23 inhibitor that has been proven to help stop further structural damage in patients with active psoriatic arthritis. Medscape Medical News Source link : https://www.medscape.com/viewarticle/guselkumab-adds-psoriatic-arthritis-structural-damage-2026a1000i12?src=rss Author : Publish date : 2026-05-29 17:39:00 Copyright for syndicated content belongs to the linked Source. The post Guselkumab Adds PsA Structural Damage Inhibition to Label first […] More

Source link : https://newshealth.biz/health-news/fda-sets-sights-on-animal-testing-ai-privacy-threat-chewing-gum-for-cancer/ The FDA issued draft guidance aimed at reducing unnecessary use of animal testing for cancer drugs. Former U.S. Attorney General Pam Bondi, 60, acknowledged that she has thyroid cancer. (People) Work requirements for Medicaid beneficiaries could lead to a dramatic increase in missed cancer screenings. (UChicago Medicine) A test for circulating tumor DNA identified patients […] […] More

Source link : https://newshealth.biz/health-news/heres-everything-wrong-with-the-offshore-ebola-quarantine-plan/ The U.S. is erecting a make-shift field hospital at the Laikipia Air Base in Central Kenya to quarantine, monitor, and treat U.S. citizens exposed to Bundibugyo ebolavirus. Built by the military and staffed by U.S. Public Health Service (PHS) personnel, the facility is intended to bypass the longstanding practice of medical evacuations to specialized U.S. […] […] More

Source link : https://newshealth.biz/health-news/traffic-pollution-linked-to-higher-rhinosinusitis-risk/ Chronic rhinosinusitis driven by different traffic pollutants may eventually require different treatments. Medscape Medical News Source link : https://www.medscape.com/viewarticle/traffic-pollution-tied-distinct-chronic-rhinosinusitis-2026a1000i17?src=rss Author : Publish date : 2026-05-29 18:20:00 Copyright for syndicated content belongs to the linked Source. The post Traffic Pollution Linked to Higher Rhinosinusitis Risk first appeared on News Health. —- Author : News Health Publish date […] More

Source link : https://health365.info/whats-unsuitable-with-how-us-and-uganda-plan-to-prevent-ebola-spreading/ As public well being employees within the Democratic Republic of Congo paintings to rein in a rising outbreak of a unprecedented Ebola virus, different nations are organising protocols for conserving their very own populations secure. As of Might 27, 2026, Congo has reported greater than 1,000 suspected and showed instances, and greater than 250 deaths, in […] More

Source link : https://newshealth.biz/health-news/nice-recommends-mepolizumab-for-uncontrolled-copd/ Mepolizumab is the second biologic approved for eosinophilic COPD this year, joining dupilumab in offering an alternative to triple therapy alone. Medscape News UK Source link : https://www.medscape.com/viewarticle/nice-recommends-mepolizumab-uncontrolled-copd-2026a1000hzz?src=rss Author : Publish date : 2026-05-29 14:17:00 Copyright for syndicated content belongs to the linked Source. The post NICE Recommends Mepolizumab for Uncontrolled COPD first appeared on News […] More

Source link : https://newshealth.biz/health-news/who-identifies-potential-ebola-therapies-vaccines-to-test-in-outbreak/ On Thursday, the World Health Organization (WHO) said its advisory groups had identified some potential therapies and vaccines to test for Ebola, but recommended they be used exclusively in clinical trials to ensure they are safe and effective. Each would require months of development. The Bundibugyo virus causing the outbreak in Congo suspected of killing […] […] More

Source link : https://newshealth.biz/health-news/gethin-jones-trains-to-be-dr-oscars-guide-runner/ 200 viewers will be joining the Morning Live team, as part of our official Couch to 5k run in Manchester. Last year, our very own Dr Punam took part – and this time, it’s all about Dr Oscar – who recently completed his training plan on the show. Dr Oscar, who is visually impaired, will […] […] More